1of3In this March 2021 photo provided by Pfizer, vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at the company's facility in Puurs, Belgium. On Wednesday, Aug. 25, 2021, the company said it started the application process for U.S. approval of a booster dose of its two-shot COVID-19 vaccine for people ages 16 and older. (Pfizer via AP)APShow MoreShow Less 2of3FILE - In this July 7, 2021 file photo, people wait after receiving the Pfizer-BioNTech COVID-19 vaccine, in a vaccination center of Lyon, central France.

https://www.theridgefieldpress.com/news/article/EU-agency-says-to-focus-on-vaccines-first-not-16430271.php

#theridgefieldpress